Dyslipidemia

US Guideline Updates in Dyslipidemia Management

This entry was posted in Cardiovascular Diseases and tagged Dyslipidemia Guideline Updates 更新 on

Recent recommendations of US guidelines highlight the importance of treating dyslipidemia earlier in life, refining cardiovascular risk assessment, and adopting lower LDL cholesterol targets to reduce long-term exposure to atherogenic lipoproteins and prevent atherosclerotic cardiovascular disease (ASCVD). Lifestyle counseling should begin in youth, with early pharmacologic therapy considered for individuals […]

AACE 2025 Updated Algorithm for Management of Dyslipidemia

This entry was posted in Cardiovascular Diseases and tagged ASCVD Dyslipidemia Update on

The American Association of Clinical Endocrinology (AACE) has released its 2025 Consensus Statement and updated algorithm for the management of adults with dyslipidemia, offering concise visual guidance and tables to support clinical decision-making aimed at reducing atherosclerotic cardiovascular disease (ASCVD) and triglyceride-induced pancreatitis risk. Developed by an international multidisciplinary task […]